Immobilized RBD of SARS-CoV-2 Spike Protein


SKU: RBD-I Categories: ,

Product Description

Immobilized RBD of SARS-CoV-2 Spike Protein

SARS-CoV-2 is the novel coronavirus that causes CoronaVirus Disease 2019 (COVID-19). The receptor-binding domain (RBD) of the SARS-CoV-2 spike protein binds to the cell receptor ACE2 allowing viral entry and infection. It is a 223 amino acid glycoprotein representing residues 319-541 of the spike protein S1 sequence. Immobilized RBD from Molecular Innovations is useful for capturing SARS-CoV-2 specific antibodies from human plasma and serum. Immobilized RBD of SARS-CoV-2 Spike Protein is highly specific and reusable. Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 6X-Histidine tag at C terminus for purification.

Produced under license from the Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Gene ID: 43740568
Swiss-Prot/UniProt ID: P0DTC2

View sample datasheet
View sample certificate of analysis
View material safety data sheet
Ask a question about this product

Additional Information



Molecular Weight

Extinction Coefficient


Shipping Conditions




Sample Size

Sample Concentration

Sample Volume

Gene Name

Gene ID

UniProt ID

You may also like…